HIC
DGX icon

Holderness Investments Company’s Quest Diagnostics DGX Stock Holding History

Holderness Investments Company’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$392K Hold
2,000
– – 0.08% 180
2025
Q4 		$347K Hold
2,000
– – 0.07% 191
2025
Q3 		$381K Hold
2,000
– – 0.08% 187
2025
Q2 		$359K Hold
2,000
– – 0.08% 190
2025
Q1 		$338K Hold
2,000
– – 0.08% 191
2024
Q4 		$302K Hold
2,000
– – 0.07% 213
2024
Q3 		$311K Hold
2,000
– – 0.07% 215
2024
Q2 		$274K Sell
2,000
-100
-5% -$13.7K 0.06% 210
2024
Q1 		$280K Hold
2,100
– – 0.07% 215
2023
Q4 		$290K Buy
+2,100
New +$276K 0.08% 201

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Holderness Investments Company's DGX Position: Q1 2026 in Review

Holderness Investments Company held its Quest Diagnostics (DGX) position steady in Q1 2026 at 2,000 shares worth $392K. The position accounts for 0.08% of the portfolio, ranked #180.

Holderness Investments Company first reported a position in DGX in Q4 2023 and has held it in 10 quarters since. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Holderness Investments Company held 2,000 shares of Quest Diagnostics worth $392K as of Q1 2026.
  • Holderness Investments Company left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up 0.08% of Holderness Investments Company's portfolio in Q1 2026, its #180 holding.
  • Holderness Investments Company first reported a position in Quest Diagnostics in Q4 2023 and has held it in 10 quarters since.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Holderness Investments Company's 13F filing for Q1 2026, filed 12 May 2026.